Skip to main content

Immunology of Tissue Transplantation

  • Chapter
Plastic and Reconstructive Surgery

Part of the book series: Springer Specialist Surgery Series ((SPECIALIST))

Summary

Composite tissue allograft (CTA) is one of the tissue reconstruction options in plastic and reconstructive surgery. Surgical techniques in CTA are well established; however, the immunologic characters of the components of CTA still require extensive research to protect allografts from rejection. CTA are histologically heterogeneous and composed of tissues such as skin, muscle, bone with bone marrow, lymph nodes, nerves, and vessels, which represent variable levels of immunogenicity and may generate different types of immunologic responses.

This chapter introduces the immunological status of CTA components, the role of immu-nomodulatory and inflammatory mediators for allograft acceptance, immune response to foreign antigens, and the hierarchy of anti-genicity of individual components of CTA compared with the whole CTA transplant.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 259.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

APC:

Antigen-presenting cells

CGRP:

Calcitonin gene-related peptide

CLA:

Cutaneous lymphocyte-associated antigen

CTA:

Composite tissue allografts

DDC:

Dermal dendritic cells

FDC:

Follicular dendritic cells

ICAM-1:

Intercellular adhesion molecule-1

LC:

Langerhans cells

MAd-CAM-1:

Mucosal addressin cellular adhesion molecule-1

MHC:

Major histocompatibility complex

OPN:

Osteopontin

SALT:

Skin-associated lymphoid tissues

SIS:

Skin immune system

Tc:

T cytotoxic

Th:

T-helper

VCAM-1:

Vascular cell adhesion molecule-1

References

  1. Figarella-Branger D, Civatte M, Bartoli C, et al. (2003) Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies. Muscle Nerve. 2003;28: 659–682.

    Article  PubMed  CAS  Google Scholar 

  2. Baggiolini M, Dewald B, Moser B. (1997) Human chemok-ines: an update. Annu Rev Immunol. 1997;15:675–705.

    Article  PubMed  CAS  Google Scholar 

  3. Dunon D, Piali L, Imhof BA. (1996) To stick or not to stick: the new leukocyte homing paradigm. Curr Opin Cell Biol. 1996;8:714–723.

    Article  PubMed  CAS  Google Scholar 

  4. Murray JE. (1971) Organ transplantation (skin, kidney, heart) and the plastic surgeon. Plast Reconstr Surg. 1971;47:425–431.

    Article  PubMed  CAS  Google Scholar 

  5. Bourget JL, Mathes DW, Nielsen G P, et al. (2001) Tolerance to musculoskeletal allografts with transient lymphocyte chimerism in miniature swine. Transplantation. 2001;71:851–856.

    Article  PubMed  CAS  Google Scholar 

  6. Buttemeyer R, Jones NF, Min Z, et al. (1996) Rejection of the component tissues of limb allografts in rats immunosuppressed with FK-506 and cyclosporine. Plast Reconstr Surg. 1996;97:139–148.

    Article  PubMed  CAS  Google Scholar 

  7. Lee WP, Yaremchuk MJ, Pan YC, et al. (1991) Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg. 1991;87:401–411.

    Article  PubMed  CAS  Google Scholar 

  8. Bos JD, Kapsenberg ML. (1993) The skin immune system: progress in cutaneous biology. Immunol Today. 1993;14:75–78.

    Article  PubMed  CAS  Google Scholar 

  9. Bos JD. (1997) Skin Immune System (SIS), 2nd edn. CRC Press, Boca Raton, New York: CRC Press.

    Google Scholar 

  10. Mathers AR, Larregina AT. (2006) Professional antigen-presenting cells of the skin. Immunol Res. 2006;36: 127–136.

    Article  PubMed  CAS  Google Scholar 

  11. Nakagawa S, Bos JD. (2001) Role of Langerhans cells in the skin. What''s new? J Eur Acad Dermatol Venereol. 2001;15:399–401.

    Article  PubMed  CAS  Google Scholar 

  12. Cumberbatch M, Dearman RJ, Kimber I. (1997) Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration. Immunology. 1997;92:388–395.

    Article  PubMed  CAS  Google Scholar 

  13. Merad M, Hoffmann P, Ranheim E, et al. (2004) Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat Med. 2004;10:510–517.

    Article  PubMed  CAS  Google Scholar 

  14. Rulifson IC, Szot GL, Palmer E, et al. (2002) Inability to induce tolerance through direct antigen presentation. Am J Transplant. 2002;2:510–519.

    Article  PubMed  CAS  Google Scholar 

  15. Bos JD, Zonneveld I, Das PK, et al. (1987) The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol. 1987;88:569–573.

    Article  PubMed  CAS  Google Scholar 

  16. Grone A. (2002) Keratinocytes and cytokines. VetImmunol Immunopathol. 2002;88:1–12.

    Article  CAS  Google Scholar 

  17. Black A P, Ardern-Jones MR, Kasprowicz V, et al. (2007) Human keratinocyte induction of rapid effector function in antigen-specific memory CD4 ++ and CD8 ++ T cells. Eur J Immunol. 2007, 37:1485–1493.

    Article  PubMed  CAS  Google Scholar 

  18. Postlethwaite AE. (1993) Dermal fibroblast function. In: Nickoloff BJ, (ed). Dermal immune system,. CRC Press, Boca Raton, FLlorida: CRC Press.

    Google Scholar 

  19. Henri S, Siret C, Machy P, et al. (2007) Mature DC from skin and skin-draining LN retain the ability to acquire and efficiently present targeted antigen. Eur J Immunol. 2007;37:1184–1193.

    Article  PubMed  CAS  Google Scholar 

  20. Blanpain C, Lowry WE, Geoghegan A, et al. (2004) Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell. 2004;118:635–648.

    Article  PubMed  CAS  Google Scholar 

  21. Paus R, Christoph T, Muller-Rover S. (1999) Immunology of the hair follicle: a short journey into terra incognita. J Investig Dermatol Symp Proc. 1999;4: 226–234.

    Article  PubMed  CAS  Google Scholar 

  22. Gilhar A, Kalish RS. (2006) Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev. 2006;5:64–69.

    Article  PubMed  Google Scholar 

  23. Wiendl H, Hohlfeld R, Kieseier BC. (2005) Muscle-derived positive and negative regulators of the immune response. Curr Opin Rheumatol. 2005;17:714–719.

    Article  PubMed  CAS  Google Scholar 

  24. Englund P, Lindroos E, Nennesmo I, et al. (2001) Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infil-trates in inflammatory myopathies. Am J Pathol. 2001;159: 1263–1273.

    Article  PubMed  CAS  Google Scholar 

  25. Karpati G, Pouliot Y, Carpenter S. (1988) Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol. 1988;23: 64–72.

    Article  PubMed  CAS  Google Scholar 

  26. Nagaraju K, Raben N, Merritt G, et al. (1998). A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clin Exp Immunol. 1998;113:407–414.

    Article  PubMed  CAS  Google Scholar 

  27. Carosella ED, Moreau P, Aractingi S, et al. (2001) HLA-G: a shield against inflammatory aggression. TrendsImmunol. 2001;22:553–555.

    CAS  Google Scholar 

  28. Behrens L, Kerschensteiner M, Misgeld T, et al. (1998) Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions. J Immunol. 1998;161: 5943–5951.

    PubMed  CAS  Google Scholar 

  29. Wiendl H, Mitsdoerffer M, Schneider D, et al. (2003) Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies. Brain. 2003;126:1026–1035.

    Article  PubMed  Google Scholar 

  30. Grant GA, Goodkin R, Kliot M. (1999) Evaluation and surgical management of peripheral nerve problems. Neurosurgery. 1999;44:825–839.

    Article  PubMed  CAS  Google Scholar 

  31. Constable AL, Armati PJ, Toyka K V, et al. (1994) Production of prostanoids by Lewis rat Schwann cells in vitro. Brain Res. 1994;635:75–80.

    Article  PubMed  CAS  Google Scholar 

  32. Armati PJ, Pollard JD, Gatenby P. (1990) Rat and human Schwann cells in vitro can synthesize and express MHC molecules. Muscle Nerve. 1990;13:106–116.

    Article  PubMed  CAS  Google Scholar 

  33. Pollard JD, McCombe PA, Baverstock J, et al. (1986) Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol. 1986;13:123–134.

    Article  PubMed  CAS  Google Scholar 

  34. Campana WM, Li X, Shubayev VI, et al. (2006) Erythropoietin reduces Schwann cell TNF-alpha, Wallerian degeneration and pain-related behaviors after peripheral nerve injury. Eur J Neurosci. 2006;23:617–626.

    Article  PubMed  Google Scholar 

  35. Kieseier BC, Hartung HP, Wiendl H. (2006) Immune circuitry in the peripheral nervous system. Curr Opin Neurol. 2006;19:437–445.

    Article  PubMed  CAS  Google Scholar 

  36. Gravallese EM. (2003) Osteopontin: a bridge between bone and the immune system. J Clin Invest. 2003;112: 147–149.

    PubMed  CAS  Google Scholar 

  37. Matsui Y, Jia N, Okamoto H, et al. (2004) Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy. Hypertension. 2004;43:1195–1201.

    Article  PubMed  CAS  Google Scholar 

  38. Whitington PF, Malladi P, Melin-Aldana H, et al. (2005) Expression of osteopontin correlates with portal biliary proliferation and fibrosis in biliary atresia. Pediatr Res. 2005;57:837–844.

    Article  PubMed  CAS  Google Scholar 

  39. Junaid A, Amara FM. (2004) Osteopontin: correlation with interstitial fibrosis in human diabetic kidney and PI3-kinase-mediated enhancement of expression by glucose in human proximal tubular epithelial cells. Histopathology. 2004;44:136–146.

    Article  PubMed  CAS  Google Scholar 

  40. Alchi B, Nishi S, Kondo D, et al. (2005) Osteopontin expression in acute renal allograft rejection. Kidney Int. 2005;67:886–896.

    Article  PubMed  CAS  Google Scholar 

  41. Thaunat O, Badet L, El-Jaafari A, et al. (2006) Composite tissue allograft extends a helping hand to transplant immunologists. Am J Transplant. 2006;6: 2238–2242.

    Article  PubMed  CAS  Google Scholar 

  42. Wekerle T, Sykes M. (2001) Mixed chimerism and transplantation tolerance. Annu Rev Med. 2001;52: 353–370.

    Article  PubMed  CAS  Google Scholar 

  43. Murase N, Starzl TE, Tanabe M, et al. (1995) Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation. 1995;60:158–171.

    PubMed  CAS  Google Scholar 

  44. Barratt-Boyes SM, Thomson AW. (2005) Dendritic cells: tools and targets for transplant tolerance. Am J Transplant. 2005;5:2807–2813.

    Article  PubMed  CAS  Google Scholar 

  45. Coates PT, Barratt-Boyes SM, Donnenberg AD, et al. (2002) Strategies for preclinical evaluation of dend-ritic cell subsets for promotion of transplant tolerance in the nonhuman primate. Hum Immunol. 2002;63:955–965.

    Article  PubMed  CAS  Google Scholar 

  46. Wang J, Dong Y, Sun JZ, et al. (2006) Donor lymphoid organs are a major site of alloreactive T-cell priming following intestinal transplantation. Am J Transplant. 2006;6:2563–2571.

    Article  PubMed  CAS  Google Scholar 

  47. Sumpio BE, Riley J T, Dardik A (2002) Cells in focus: endo-thelial cell. Int J Biochem Cell Biol. 2006;34:1508–1512.

    Article  PubMed  CAS  Google Scholar 

  48. Ma W, Pober JS. (1998) Human endothelial cells effectively costimulate cytokine production by, but not differentiation of, naive CD4 ++ T cells. J Immunol. 1998;161:2158–2167.

    PubMed  CAS  Google Scholar 

  49. Siemionow M, Demir Y, Mukherjee A, et al. (2005) Development and maintenance of donor-specific chi-merism in semi-allogenic and fully major histocom-patibility complex mismatched facial allograft transplants. Transplantation. 2005;79:558–567.

    Article  PubMed  CAS  Google Scholar 

  50. Siemionow M, Izycki D, Ozer K, et al. (2006) Role of thy-mus in operational tolerance induction in limb allograft transplant model. Transplantation. 2006;81:1568–1576.

    Article  PubMed  Google Scholar 

  51. Siemionow MZ, Izycki DM, Zielinski M. (2003) Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol. Transplantation. 2003;76:1662–1668.

    Article  PubMed  CAS  Google Scholar 

  52. Mathes DW, Randolph MA, Solari MG, et al. (2003) Split tolerance to a composite tissue allograft in a swine model. Transplantation. 2003;75:25–31.

    Article  PubMed  CAS  Google Scholar 

  53. Tung TH, Mohanakumar T, Mackinnon SE. (2005) TH1/TH2 cytokine profile of the immune response in limb component transplantation. Plast Reconstr Surg. 2005;116:557–566.

    Article  PubMed  CAS  Google Scholar 

  54. Kanitakis J, Jullien D, Claudy A, et al. (1999) Microchi-merism in a human hand allograft. Lancet. 1999;354: 1820–1821.

    Article  PubMed  CAS  Google Scholar 

  55. Delis S, Ciancio G, Burke GW, III et al. (2004) Donor bone marrow transplantation: chimerism and tolerance. Transpl Immunol. 2004;13:105–115.

    Article  PubMed  CAS  Google Scholar 

  56. Devauchelle B, Badet L, Lengele B, et al. (2006) First human face allograft: early report. Lancet. 2006;368: 203–209.

    Article  PubMed  Google Scholar 

  57. Blaha P, Bigenzahn S, Koporc Z, et al. (2005) Short-term immunosuppression facilitates induction of mixed chimerism and tolerance after bone marrow transplantation without cytoreductive conditioning. Transplantation. 2005;80:237–243.

    Article  PubMed  CAS  Google Scholar 

  58. Klimczak A, Unal S, Jankowska A, et al. (2007) Donor-origin cell engraftment after intraosseous or intravenous bone marrow transplantation in a rat model. Bone Marrow Transplant. 2007;40:373–380.

    Article  PubMed  CAS  Google Scholar 

  59. Siemionow M, Ozer K, Izycki D, et al. (2005) A new method of bone marrow transplantation leads to extension of skin allograft survival. Transplant Proc. 2005;37:2309–2314.

    Article  PubMed  CAS  Google Scholar 

  60. Rennert PD, Hochman PS, Flavell RA, et al. (2001) Essential role of lymph nodes in contact hypersensitivity revealed in lymphotoxin-alpha-deficient mice. J Exp Med. 2001;193:1227–1238.

    Article  PubMed  CAS  Google Scholar 

  61. Lakkis FG, Arakelov A, Konieczny BT, et al. (2000) Immunologic “ignorance” of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med. 2000;6:686–688.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag London Limited

About this chapter

Cite this chapter

Klimczak, A., Siemionow, M. (2010). Immunology of Tissue Transplantation. In: Siemionow, M.Z., Eisenmann-Klein, M. (eds) Plastic and Reconstructive Surgery. Springer Specialist Surgery Series. Springer, London. https://doi.org/10.1007/978-1-84882-513-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-84882-513-0_2

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84882-512-3

  • Online ISBN: 978-1-84882-513-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics